Jazz Pharmaceuticals
JAZZ
$129.44
Share price
-1.21%
Change (1 day)
-14.65%
Change (1 year)
Categories
Jazz Pharmaceuticals (JAZZ) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $7.73 B
According to Jazz Pharmaceuticals's latest financial reports the company's total liabilities are $7.73 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Jazz Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $7.74 B | -7.01% |
| 2021-12-31 | $8.33 B | 189.74% |
| 2020-12-31 | $2.87 B | 18.46% |
| 2019-12-31 | $2.42 B | -0.74% |
| 2018-12-31 | $2.44 B | 1.47% |
| 2017-12-31 | $2.41 B | -17.53% |
| 2016-12-31 | $2.92 B | 65.98% |
| 2015-12-31 | $1.76 B | -10.51% |
| 2014-12-31 | $1.96 B | 108.74% |
| 2013-12-31 | $0.94 B | 11.53% |
| 2012-12-31 | $0.84 B | 1290.48% |
| 2011-12-31 | $60.78 M | -42.21% |
| 2010-12-31 | $0.10 B | -41.64% |
| 2009-12-31 | $0.18 B | -14.33% |
| 2008-12-31 | $0.21 B | 37.9% |
| 2007-12-31 | $0.15 B | -60.97% |
| 2006-12-31 | $0.39 B | 38.1% |
| 2005-12-31 | $0.28 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $59.04 B | 663.40% | 🇨🇭 Switzerland |
 AmerisourceBergen
ABC | $60.25 B | 679.01% | 🇺🇸 USA |
 Endo International
ENDPQ | $9.54 B | 23.42% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | $35.38 B | 357.50% | 🇮🇱 Israel |